Methyl Alcohol

Methyl Alcohol

SCHEMBL2285565

C1COCCOCCOCCOCCOCCO1.CO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.67
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TSHR P16473 3/20 0.36
KDM4E B2RXH2 2/20 0.32
GAA P10253 1/20 0.31
CYP2C9 P11712 1/20 0.31
USP2 O75604 1/20 0.31
PKM P14618 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30
HSD17B10 Q99714 1/20 0.30
LMNA P02545 1/20 0.30
CRHBP P24387 1/20 0.30
HTT P42858 1/20 0.30
CRHR2 Q13324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dioxane SCHEMBL10791372 1.00 TTR (0.67) TTRALDH1A1SMN1; SMN2MEN1KMT2A
Dioxane SCHEMBL234551 1.00
Dioxane SCHEMBL11079749 0.95
Dioxane SCHEMBL11079311 0.95
Dioxane SCHEMBL11074566 0.95
Dioxane SCHEMBL11073120 0.95
Dioxane SCHEMBL3355965 0.95
Oxirane SCHEMBL844515 0.94
Dioxane SCHEMBL28216951 0.87 ALDH1A1 (0.67) TTRALDH1A1SMN1; SMN2MEN1KMT2A
Dioxane SCHEMBL7807843 0.83 ALDH1A1 (0.46) TTRALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8007871-B2 Electrospray deposition: devices and methods thereof NANOSELECT, INC. (US) 2011-08-30 US disclosed
US-7696361-B2 Chemical reagents capable of selective attachment to and reaction with peptides and proteins CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2010-04-13 US disclosed
US-20100068406-A1 ELECTROSPRAY DEPOSITION: DEVICES AND METHODS THEREOF NANOSELECT, INC. 2010-03-18 US disclosed
WO-2007089650-A2 ELECTROSPRAY DEPOSITION: DEVICES AND METHODS THEREOF NANOSELECT, INC. (US) 2007-08-09 WO disclosed
US-20050010059-A1 Chemical reagents capable of selective attachment to and reaction with peptides and proteins CALIFORNIA INSTITUTE OF TECHNOLOGY 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010059-A1 Chemical reagents capable of selective attachment to and reaction with peptides and proteins PTMS, FGB, DNPEP TTR 426/4885ALDH1A1 4309/4885SMN1; SMN2 4205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.